What Remediiate does

Remediiate Ltd. is a UK-based Carbon Capture and Utilisation (CCU) company, founded in 2017, that converts industrial Scope 1 CO2 emissions into microalgae biomass via proprietary photobioreactor systems. Its platform is TRL-8 ready and represents the first commercially proven CCU solution deployed at industrial scale, with the foundation installation at Vale Nickel Refinery in Swansea, Wales (the site emits 36,000 tonnes of CO2 per year). The company positions itself as the only CCU provider that does not require rare earth elements or critical minerals, and it is approved for deployment in COMAH-compliant facilities.

The core technology stack comprises four integrated modules: a patent-pending photobioreactor (PBR) with proprietary lighting, internal topology, aeration and CO2 dosing designed to maximise photon exposure and productivity; a library of species-specific Growth Protocols that recreate optimal cultivation conditions including CO2 dosing, nutrient delivery and circadian cycle management; a patented rapid dewatering and drying system that processes biomass in minutes rather than hours at an order of magnitude lower cost than traditional methods; and a cloud-based, machine-learning Command & Control AI system that monitors hundreds of sensors, identifies optimal harvest timing, drives SCADA operations, and predicts maintenance needs. Outputs include microalgae biomass targeted at animal feed, with secondary applications in building materials.

Remediiate generates revenue from two streams: offtake product sales (microalgae biomass sold to animal feed producers and other downstream industries) and carbon abatement services to industrial emitters. Its go-to-market is direct enterprise field sales with deployment co-located at emitter sites, supported by thought leadership content, conference presence (e.g., Carbon Capture Europe 2026), and resource-library marketing. Confirmed enterprise customers/partners include Vale (foundation client, mining/metals), ForFarmers (offtake, animal feed), Swansea University, Haden Freeman (engineering design), and UK government backers DESNZ and Innovate UK. Headcount is reported at 1-10 employees.

Name

Remediiate

Legal name

Remediiate Ltd.

Website

https://remediiate.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

1–10 employees

Short description

Remediiate Ltd. is a UK-based carbon capture and utilisation company that converts industrial CO2 emissions into microalgae biomass for animal feed and other products, using proprietary photobioreactor systems deployed at industrial emitter sites.

Ownership category

akta.pro rank

Product category

Industrial Carbon Capture Services

NAICS

Remediation Services (562910)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Biomass Carbon Removal & Storage (BECCS/Bioenergy with CO₂ Capture) (EUABAFAB)

Keywords

• Carbon Capture Utilisation
• Microalgae Cultivation
• Industrial Emissions Reduction
• Bioreactor Technology
• Carbon Abatement Services

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Microalgae offtake product sales: Sale of harvested microalgae biomass to animal feed producers and other industries. The company provides end-to-end solution from capture to sale and distribution of offtake products, generating revenue from the commercialization of carbon-derived biomass.
2. Carbon abatement services: Processing waste carbon directly at source for industrial emitters, enabling them to meet regulatory obligations and Net Zero objectives while converting emissions into valuable assets.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Remediiate provides an end-to-end Carbon Capture and Utilisation (CCU) solution that processes industrial CO2 emissions at source, cultivating microalgae through proprietary photobioreactors, and converting the captured carbon into valuable biomass for animal feed and other commercial offtake applications. The company delivers site evaluation, deployment, and ongoing operation of its TRL-8 ready CCU system, then commercializes the resulting microalgae biomass.

Product overview

Remediiate offers a unified CCU (Carbon Capture and Utilisation) platform centered on its TRL8-ready microalgae cultivation system. The core Remediiate CCU Solution processes industrial CO2 emissions at source through four integrated modules: Growth Protocols (optimized cultivation recipes), Photobioreactor Technology (patent-pending cultivation vessels), Harvesting Technology (patented dewatering/drying), and the Command & Control AI System (machine-learning automation). The platform converts captured CO2 into microalgae biomass via algal photosynthesis, producing valuable offtake products for animal feed and building materials. The system is the first commercially proven CCU solution at industrial scale, deployed at Vale Nickel refinery.

Differentiator

Problem solved

Functional benefit

Products and services

• Remediiate CCU Solution End-to-end TRL-8 ready Carbon Capture and Utilisation solution that captures industrial Scope 1 CO2 emissions at source and converts them into valuable microalgae biomass through proprietary algal photosynthesis. Includes site evaluation, deployment, and sale of offtake products. Deployed at industrial emitter facilities.
• Microalgae Offtake Products Enriched algal biomass produced from the CCU process, harvested and commercialised for downstream uses including animal feed, agricultural products, and building materials. Provides protein-rich nutritional supplement and alternative protein source for feed manufacturers.

Quantifiable outcome

• 2 tonnes of CO2 produces 1 tonne of offtake + 1 tonne of O2
• +4 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Partnerships

Five partnerships are on record, tiered core and minor.

• Swansea UniversitycoreStrategic or Co-development PartnerAcademic partner collaborating on microalgae research. Professor Darren Oatley-Radcliffe serves as Chair of Low Carbon Energy and Environment. Partnership aligned with university's Reduction In Carbon Emissions (RICE) programme.
• ForFarmerscoreStrategic or Co-development PartnerEuropean animal feed company involved in developing alternative proteins including microalgae for animal feed. Exploring carbon capture potential at scale for circular food systems.
• Haden FreemancoreImplementation/ SI/ Consulting PartnerEngineering design partner supporting development of investment accuracy across project portfolio and into design. Selected as design engineering partner for next phase of growth.
• ValecoreStrategic or Co-development PartnerFoundation client where first commercially viable CCU solution was proven at industrial scale at Vale Nickel Refinery. Managing Director Darren Poland optimistic about eliminating costs on journey to Net Zero.
• IDTechExminorOthersIndependent market research provider that profiled Remediiate's innovative CCU solution.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Climeworks: Climeworks is a leading direct air capture (DAC) company at commercial scale — a broader incumbent in industrial carbon capture, comparable to Remediiate on the climate-solutions buyer landscape but pursuing DAC rather than point-source CCU.
• Corbion: Corbion is an established global biotech producing algae-based ingredients (including omega-3s from microalgae) at industrial scale for food, feed, and personal care — comparable as a scaled incumbent in microalgae-derived offtake markets Remediiate is targeting.

Direct peers

• CarbonCure Technologies: CarbonCure commercializes CO2 utilization for the concrete and construction sector, injecting captured CO2 into building materials — directly comparable as a CCU player monetizing captured carbon through construction-material offtake, one of Remediiate's stated end markets.
• AlgaEnergy: AlgaEnergy is a microalgae biotechnology company developing microalgae-based products for agriculture, nutrition, and cosmetics — directly comparable as a microalgae cultivation platform pursuing commercial offtake in similar end markets (feed, agriculture, biomaterials).
• Novonutrients: Novonutrients uses microbes (including microalgae-related biology) to convert industrial CO2 emissions into protein ingredients for animal feed and aquaculture — directly comparable on the CO2-to-microalgae-protein-for-feed value chain that is Remediiate's core offtake thesis.
• LanzaTech: LanzaTech operates a commercial CCU platform using gas-fermenting microbes to convert industrial CO2 and waste gases into fuels and chemicals — directly comparable as a CCU-as-a-service business converting industrial emissions into valuable offtake products at industrial scale.

Emerging players

• Origin Materials: Origin Materials converts biomass feedstocks into low-carbon chemicals and materials for construction and packaging — an emerging player in bio-based building materials and offtake chemistry, overlapping with Remediiate's biomass-to-construction-material use case.
• Prometheus Materials: Prometheus Materials produces bio-based, carbon-sequestering building materials using microalgae biomass — an emerging player directly comparable on the microalgae-to-construction-materials value chain Remediiate has identified as a secondary offtake segment.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/remediiate

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Remediiate